February 21, 2025

ChatGPT Has Limitations in Clinical Utility for Colorectal Cancer but May Be Useful for Patient Education

A study to be presented at the 2025 ASCO Gastrointestinal Cancers Symposium evaluated the chatbot’s ability to accurately respond to patient inquiries regarding colon cancer by comparing its responses...

The ASCO Post

February 19, 2025

Higher Calcium Intake Cuts Colorectal Cancer: Study

New NIH-AARP study of 471,396 participants shows increased calcium intake from all sources associated with significantly lower colorectal cancer risk over 20+ years of follow-up.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 14, 2025

ctDNA and Immunoscore in Resected Stage III Colon Cancer

As reported in the Journal of Clinical Oncology by Taieb et al, a combined analysis of two phase III adjuvant trials (IDEA-France and  IDEA-Greece) in stage III colon cancer showed that the presence o...

The ASCO Post

February 13, 2025

Yogurt May Reduce Some Colorectal Cancer Risk

New research shows long-term yogurt consumption correlates with reduced risk of Bifidobacterium-positive colorectal cancer, particularly in the proximal colon, according to a 132,056-participant study published in Gut Microbes.

Conexiant

February 13, 2025

New Findings on Aspirin and Risk of Colorectal Cancer Recurrence

In one of the first biomarker-driven randomized studies in patients with nonmetastatic colorectal cancer, researchers explored whether taking 160 mg of aspirin daily after treatment ended could reduce...

The ASCO Post

February 11, 2025

H pylori: A Hidden Cancer Risk?

Microbial infections like H. pylori drive inflammation, oxidative DNA damage, and immune suppression, fueling cancer initiation and progression.

Conexiant

February 06, 2025

AI-Assisted Quality Control Improves Adenoma Detection in Colonoscopy

An automatic quality control system was associated with a statistically significant increase in adenoma detection rates in routine colonoscopy.

Conexiant

January 27, 2025

New Research Explores Blood Test to Determine Prognosis, Benefit of Celecoxib in Stage III Colon Cancer

Previous research has shown that nonsteroidal antiinflammatory drugs, including aspirin and COX-2 inhibitors, may reduce the risk of developing colon cancer. A recent study from CALGB/SWOG evaluated t...

The ASCO Post